Timing of removal of transluminal stents after endoscopic drainage of pancreatic fluid collections: a randomized controlled multicenter trial.
Completed
- Conditions
- Pancreatic pseudocyst10017943
- Registration Number
- NL-OMON39383
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 55
Inclusion Criteria
* Patient over 18 years old
* PFC resolution (no remaining fluid collection larger than 3 cm)
* Pigtail(s) positioned in remnant PFC
* Abnormal PD on S-MRCP performed 12-16 weeks after drainage
- ductal dilation (* 5 mm in body or tail)
- ductal disruption
- both ductal dilation and ductal disruption
Exclusion Criteria
* PFC complicating chronic pancreatitis
* PFC after surgery
* Recurrence of prior treated PFC
* Acute-on-chronic pancreatitis
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Recurrence of a PFC (>6 cm or symptomatic) proximal to the initial PD<br /><br>disruption after endoscopic drainage at or within 18 months after initial<br /><br>drainage</p><br>
- Secondary Outcome Measures
Name Time Method <p>* Complications such as infection, pain that could be associated to leaving<br /><br>stents in situ<br /><br>* Number of spontaneous stent migrations before removal</p><br>